What are the possible causes of meningoencephalitis with cerebrospinal fluid showing a lymphocytic pleocytosis of >1000 white blood cells, markedly elevated protein (~1244 mg/dL), and normal glucose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differential Diagnosis: Severe Lymphocytic Meningoencephalitis

This CSF profile—with >1000 lymphocytes, markedly elevated protein (1244 mg/dL), and normal glucose—is atypical and demands urgent consideration of tuberculous meningitis, autoimmune encephalitis (particularly anti-GFAP), partially treated bacterial meningitis, or less commonly, severe viral encephalitis or neurobrucellosis.

Key Clinical Context

The CSF findings you describe are highly unusual because most viral encephalitis cases have <1000 WBC/mm³ 1. This extreme lymphocytic pleocytosis with massively elevated protein but preserved glucose creates a specific pattern that narrows the differential significantly.

Primary Diagnostic Considerations

1. Tuberculous Meningitis (Most Critical)

  • This is the most dangerous diagnosis to miss given the mortality implications
  • Classic CSF pattern: lymphocytic pleocytosis, markedly elevated protein (often >500 mg/dL), and LOW glucose
  • However, early TB meningitis or partially treated cases can present with normal glucose initially
  • The protein level of 1244 mg/dL is particularly concerning for TB, as this degree of elevation is uncommon in viral infections
  • Look for: subacute onset over days-weeks, basilar meningeal enhancement on MRI, cranial nerve palsies, hydrocephalus, history of TB exposure or immunosuppression

2. Autoimmune Encephalitis (Anti-GFAP)

  • Anti-GFAP encephalitis specifically presents with marked lymphocytic pleocytosis and can have WBC counts >1000 2
  • Often follows viral prodrome, which may explain initial infectious presentation
  • Look for: linear perivascular radial gadolinium enhancement on MRI, rapid progression to coma, preceding viral-like illness
  • CSF anti-GFAP antibodies are diagnostic
  • Critical: This requires immunotherapy (IVIG, steroids, plasma exchange, rituximab) rather than antimicrobials 2

3. Partially Treated Bacterial Meningitis

  • Prior antibiotic exposure can convert neutrophilic to lymphocytic predominance
  • Protein elevation of this magnitude can occur with bacterial meningitis
  • Crucially, bacterial meningitis with normal CSF glucose is rare but documented, particularly in immunocompromised patients 3
  • CSF Gram stain and culture remain essential—bacteria may still be visible even with normal WBC counts in some cases 3

4. Severe Viral Encephalitis (Less Likely)

  • While most viral encephalitis has <1000 WBC 1, exceptions exist
  • HSV encephalitis typically has lower cell counts but can occasionally present atypically
  • Important: 23.7% of HSV-1 encephalitis cases have NO pleocytosis 4, so the presence of >1000 cells doesn't exclude HSV but makes it less typical
  • Normal glucose favors viral over bacterial, but protein of 1244 is unusually high for typical viral causes

5. Neurobrucellosis

  • Endemic regions: consider in stockmen, shepherds, or those with animal exposure 5
  • Typically presents with mild CSF pleocytosis (<50 cells common), but severe cases can occur
  • Protein >500 mg/dL is rare in neurobrucellosis 5, making this less likely with protein of 1244
  • Normal to mildly decreased glucose

Critical Diagnostic Algorithm

Immediate actions while awaiting specific test results:

  1. Start empiric therapy immediately covering:

    • HSV: Acyclovir 10 mg/kg IV q8h (do NOT delay for lack of pleocytosis 4)
    • TB: If any clinical suspicion (subacute course, basilar enhancement, immunosuppression), start RIPE therapy
    • Bacterial: If any concern for partially treated bacterial meningitis, continue/start appropriate antibiotics
  2. Send CSF for:

    • HSV PCR (sensitivity 96-98% 6)
    • TB: AFB smear, culture, GeneXpert/PCR, adenosine deaminase
    • Autoimmune panel: anti-GFAP, anti-NMDAR, other neuronal antibodies
    • Bacterial culture (even if prior antibiotics given)
    • Brucella serology if epidemiologically relevant
  3. MRI brain with contrast:

    • Temporal lobe involvement → HSV
    • Basilar meningeal enhancement, hydrocephalus → TB
    • Linear perivascular enhancement → anti-GFAP 2
  4. Clinical history priorities:

    • Timeline: hyperacute (hours) vs acute (days) vs subacute (weeks)
    • Prior antibiotics (any amount can alter CSF profile)
    • Immunosuppression status
    • TB exposure or risk factors
    • Recent viral illness (suggests autoimmune)
    • Animal/occupational exposure (brucellosis)

Common Pitfalls

  • Do not withhold acyclovir based on atypical CSF findings—HSV can present without pleocytosis 4 and delayed treatment increases mortality
  • Do not assume viral based on lymphocytic predominance and normal glucose alone—TB and autoimmune causes are critical alternatives
  • Do not wait for culture results to start TB therapy if clinical suspicion exists—TB meningitis has high mortality if treatment is delayed
  • The protein level of 1244 mg/dL is exceptionally high and should raise suspicion beyond typical viral causes 1

Immunocompromised Patients

If the patient is immunocompromised, expand differential to include:

  • CMV encephalitis (though typically has minimal or no pleocytosis 7)
  • Cryptococcal meningitis (check CSF cryptococcal antigen, India ink)
  • Toxoplasmosis
  • Lymphomatous meningitis

The combination of >1000 lymphocytes with protein >1200 mg/dL and normal glucose is sufficiently atypical that empiric coverage for TB and autoimmune causes should be strongly considered while pursuing definitive diagnosis 1, 6, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.